These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 9780251)

  • 21. HIV-specific cytotoxic T lymphocytes, HLA-A11, and chemokine-related factors may act synergistically to determine HIV resistance in CCR5 delta32-negative female sex workers in Chiang Rai, northern Thailand.
    Sriwanthana B; Hodge T; Mastro TD; Dezzutti CS; Bond K; Stephens HA; Kostrikis LG; Limpakarnjanarat K; Young NL; Qari SH; Lal RB; Chandanayingyong D; McNicholl JM
    AIDS Res Hum Retroviruses; 2001 May; 17(8):719-34. PubMed ID: 11429112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Longitudinal analysis of human immunodeficiency virus type 1-specific cytotoxic T lymphocyte responses: a predominant gag-specific response is associated with nonprogressive infection.
    Pontesilli O; Klein MR; Kerkhof-Garde SR; Pakker NG; de Wolf F; Schuitemaker H; Miedema F
    J Infect Dis; 1998 Oct; 178(4):1008-18. PubMed ID: 9806028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytolytic T lymphocytes (CTLs) from HIV-1 subtype C-infected Indian patients recognize CTL epitopes from a conserved immunodominant region of HIV-1 Gag and Nef.
    Thakar MR; Bhonge LS; Lakhashe SK; Shankarkumar U; Sane SS; Kulkarni SS; Mahajan BA; Paranjape RS
    J Infect Dis; 2005 Sep; 192(5):749-59. PubMed ID: 16088824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unique acquisition of cytotoxic T-lymphocyte escape mutants in infant human immunodeficiency virus type 1 infection.
    Pillay T; Zhang HT; Drijfhout JW; Robinson N; Brown H; Khan M; Moodley J; Adhikari M; Pfafferott K; Feeney ME; St John A; Holmes EC; Coovadia HM; Klenerman P; Goulder PJ; Phillips RE
    J Virol; 2005 Sep; 79(18):12100-5. PubMed ID: 16140787
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting of HIV-1 antigens for rapid intracellular degradation enhances cytotoxic T lymphocyte (CTL) recognition and the induction of de novo CTL responses in vivo after immunization.
    Tobery TW; Siliciano RF
    J Exp Med; 1997 Mar; 185(5):909-20. PubMed ID: 9120397
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhancement of human immunodeficiency virus (HIV)-specific CD4+ and CD8+ cytotoxic T-lymphocyte activities in HIV-infected asymptomatic patients given recombinant gp160 vaccine.
    Kundu SK; Katzenstein D; Moses LE; Merigan TC
    Proc Natl Acad Sci U S A; 1992 Dec; 89(23):11204-8. PubMed ID: 1360665
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytotoxic T lymphocyte activity and CD8 subpopulations in children at risk of HIV infection.
    Aldhous MC; Watret KC; Mok JY; Bird AG; Froebel KS
    Clin Exp Immunol; 1994 Jul; 97(1):61-7. PubMed ID: 8033422
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between human immunodeficiency virus type 1 (HIV-1)-specific memory cytotoxic T lymphocytes and virus load after recent HIV-1 seroconversion.
    Connick E; Schlichtemeier RL; Purner MB; Schneider KM; Anderson DM; MaWhinney S; Campbell TB; Kuritzkes DR; Douglas JM; Judson FN; Schooley RT
    J Infect Dis; 2001 Dec; 184(11):1465-9. PubMed ID: 11709791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection.
    Musey L; Hughes J; Schacker T; Shea T; Corey L; McElrath MJ
    N Engl J Med; 1997 Oct; 337(18):1267-74. PubMed ID: 9345075
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-HIV type 1 cytotoxic T lymphocyte effector activity and disease progression in the first 8 years of HIV type 1 infection of homosexual men.
    Rinaldo CR; Beltz LA; Huang XL; Gupta P; Fan Z; Torpey DJ
    AIDS Res Hum Retroviruses; 1995 Apr; 11(4):481-9. PubMed ID: 7632463
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comprehensive screening for human immunodeficiency virus type 1 subtype-specific CD8 cytotoxic T lymphocytes and definition of degenerate epitopes restricted by HLA-A0207 and -C(W)0304 alleles.
    Currier JR; deSouza M; Chanbancherd P; Bernstein W; Birx DL; Cox JH
    J Virol; 2002 May; 76(10):4971-86. PubMed ID: 11967314
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carboxyl-terminal and central regions of human immunodeficiency virus-1 NEF recognized by cytotoxic T lymphocytes from lymphoid organs. An in vitro limiting dilution analysis.
    Hadida F; Parrot A; Kieny MP; Sadat-Sowti B; Mayaud C; Debre P; Autran B
    J Clin Invest; 1992 Jan; 89(1):53-60. PubMed ID: 1370302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation of maternal cytophilic human immunodeficiency virus (HIV)-1 V3 loop peptide-specific antibodies in infants with vertical HIV transmission.
    Wang XP; Oyaizu N; Pahwa S
    Pediatr Res; 1995 Sep; 38(3):384-9. PubMed ID: 7494664
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cross-reactive cytotoxic T lymphocytes induced by V3 loop synthetic peptides from different strains of human immunodeficiency virus type 1.
    Casement KS; Nehete PN; Arlinghaus RB; Sastry KJ
    Virology; 1995 Aug; 211(1):261-7. PubMed ID: 7645219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection. Breadth and specificity of the response and relation to in vivo viral quasispecies in a person with prolonged infection and low viral load.
    Harrer T; Harrer E; Kalams SA; Barbosa P; Trocha A; Johnson RP; Elbeik T; Feinberg MB; Buchbinder SP; Walker BD
    J Immunol; 1996 Apr; 156(7):2616-23. PubMed ID: 8786327
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of highly conserved and broadly cross-reactive HIV type 1 cytotoxic T lymphocyte epitopes as candidate immunogens for inclusion in Mycobacterium bovis BCG-vectored HIV vaccines.
    Ferrari G; Kostyu DD; Cox J; Dawson DV; Flores J; Weinhold KJ; Osmanov S
    AIDS Res Hum Retroviruses; 2000 Sep; 16(14):1433-43. PubMed ID: 11018863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diversity of the human immunodeficiency virus type 1 (HIV-1) env sequence after vertical transmission in mother-child pairs infected with HIV-1 subtype A.
    Verhofstede C; Demecheleer E; De Cabooter N; Gaillard P; Mwanyumba F; Claeys P; Chohan V; Mandaliya K; Temmerman M; Plum J
    J Virol; 2003 Mar; 77(5):3050-7. PubMed ID: 12584330
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of cross-clade CTL epitopes in HIV-1 clade A/E-infected individuals by using the clade B overlapping peptides.
    Watanabe K; Murakoshi H; Tamura Y; Koyanagi M; Chikata T; Gatanaga H; Oka S; Takiguchi M
    Microbes Infect; 2013 Nov; 15(13):874-86. PubMed ID: 23968885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytotoxic T lymphocyte responses in the peripheral blood of children born to human immunodeficiency virus-1-infected mothers.
    Cheynier R; Langlade-Demoyen P; Marescot MR; Blanche S; Blondin G; Wain-Hobson S; Griscelli C; Vilmer E; Plata F
    Eur J Immunol; 1992 Sep; 22(9):2211-7. PubMed ID: 1381309
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple CTL specificities against autologous HIV-1-infected BLCLs.
    Ahearne PM; Morgan RA; Sebastian MW; Bolognesi DP; Weinhold KJ
    Cell Immunol; 1995 Mar; 161(1):34-41. PubMed ID: 7867083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.